As of December 2024, Samjin Pharmaceuticals has a market cap of $161.99M. This makes Samjin Pharmaceuticals the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $184.85M | -4.17% |
2023 | $192.88M | -15.79% |
2022 | $229.05M | -2.47% |
2021 | $234.85M | -3.49% |
2020 | $243.34M | 9.22% |
2019 | $222.80M | -37.86% |
2018 | $358.53M | 11.99% |
2017 | $320.13M | 3.17% |
2016 | $310.31M | 49.46% |
2015 | $207.62M | 8.64% |
2014 | $191.10M | 48.10% |
2013 | $129.03M | 35.68% |
2012 | $95.10M | 33.96% |
2011 | $70.99M | -30.26% |
2010 | $101.80M | -5.58% |
2009 | $107.81M | 44.65% |
2008 | $74.53M | -24.57% |
2007 | $98.81M | 25.77% |
2006 | $78.56M | -5.93% |
2005 | $83.51M | - |